This ETF has been the tip of the arrow when it comes to trading momentum stocks.» Read More
NEW YORK, April 15- U.S. stocks fell on Tuesday as early gains evaporated when momentum shares once again lost ground, overshadowing a jump in Coca-Cola and Johnson& Johnson after their quarterly earnings. Tesla Motors Inc fell 5.5 percent to $187.25 and NetFlix Inc dropped 4.5 percent to $316.82 to rank among the worst performers in the Nasdaq 100 index.
April 8- The last six weeks have been rough for investors who jumped into 2013' s big stock market winners like Netflix and Facebook, only to see their share prices crater. For now, they have shifted money to other parts of the equities market, instead of retreating to safe-havens like cash, and concerns that there will be a full-scale retreat are muted.
Familiar names such as Netflix, Facebook and Tesla Motors, along with a number of biotechnology and cloud-computing stocks, have been pummeled in the last month. Facebook Inc, for example, has fallen nearly 22 percent from an intraday record reached less than a month ago.
Intuitive Surgical fell 5 percent to $513.42 while Alexion Pharmaceuticals slid 4 percent to $145.37. TripAdvisor Inc sank 5 percent to $86.75 and Netflix Inc shed 3.8 percent to trade at $341.39.
A high-priced drug sold by Gilead Sciences is under lawmakers' scrutiny. But one analyst says there's a bigger problem.
*Gold drops on concerns about U.S. rate hike. *Slowing growth in Germany, China weighs on some investors. NEW YORK, March 24- Global equity markets fell on Monday, rattled by the ongoing Ukraine crisis and weak data from China, while gold fell on concerns about higher U.S. interest rates and a stronger dollar.
Some of Tuesday's midday movers:
There is worry that the recent decline in copper and China's economic woes might be the start of a wider correction.
*Boeing finds cracks in wings of Dreamliners in production. *Facebook shares hit another record after UBS raises target. NEW YORK, March 10- U.S. stocks dipped on Monday, weighed down by soft data out of China and Boeing's latest production setback.
*Facebook shares hit another record after UBS raises target. NEW YORK, March 10- U.S. stocks fell on Monday weighed by soft data out of China, lingering concerns over Russia's claim over part of Ukraine and Boeing's latest production setback.
Some of Monday's midday movers:
Soliris, the company's sole product on the market, is approved in the United States, the European Union and Japan for the two conditions. The drugmaker raised its full-year adjusted earnings forecast to $4.37- $4.47 per share from its previous estimate of $3.70- $3.80.
Some of the names on the move ahead of the open.
March 10- Alexion Pharmaceuticals Inc revised its profit and sales outlook for the year after the French government agreed to raise reimbursement payments for the company's lead drug, Soliris. The drugmaker raised its full-year adjusted earnings forecast to $4.37- $4.47 per share from its previous estimate of $3.70- $3.80 per share.
Talk about following the money. Investors looking to beat the S&P 500 need only track companies that are spending the most money lobbying Washington.
*Hasbro rallies after results, upbeat comments. NEW YORK, Feb 10- U.S. stocks ended with modest gains on Monday as investors digested recent market gains and looked ahead to new Federal Reserve Chair Janet Yellen's first testimony before lawmakers.
Jan 30- Shares of Alexion Pharmaceuticals Inc soared 27 percent to a life-high after the company forecast $2 billion in sales for its blood disorder drug this year ahead of analysts' average estimate.
Some of Thursday's midday movers:
Jan 30- Alexion Pharmaceuticals Inc said it expected revenue from its blood disorder drug, Soliris, to hit the $2 billion mark in 2014, sending its shares up 27 percent to a life-high. Sales are expected to rise to between $2 billion to $2.02 billion in 2014 from $1.55 billion in 2013..
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.